{"id":75443,"date":"2026-11-09T05:12:37","date_gmt":"2026-11-09T02:12:37","guid":{"rendered":"https:\/\/www.pharmamanage.gr\/future-pharmacy-reimbursement-models-explained\/"},"modified":"2026-11-09T05:12:37","modified_gmt":"2026-11-09T02:12:37","slug":"future-pharmacy-reimbursement-models-explained","status":"publish","type":"post","link":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/","title":{"rendered":"Future Pharmacy Reimbursement Models Explained"},"content":{"rendered":"

A prescription that is filled accurately, on time, and with meaningful patient counseling creates value well beyond the cost of a product. Yet traditional payment structures have often treated the pharmacy primarily as a dispensing point. Future pharmacy reimbursement models will be shaped by a more difficult question: how should pharmacies be paid for the access, clinical judgment, adherence support, and operational infrastructure they provide?<\/p>\n

For pharmacy owners and managers, this is not an abstract policy discussion. Reimbursement determines whether expanded services can be staffed, whether technology investments can be justified, and whether the business can remain economically stable while prescription volume rises. The direction of travel is clear, even if the pace varies by payer, state, and market segment: payment is moving toward greater transparency, greater accountability, and a broader recognition of pharmacy-delivered care.<\/p>\n

Why the traditional dispensing model is under pressure<\/h2>\n

The conventional model combines ingredient cost reimbursement with a dispensing fee, often mediated through pharmacy benefit managers. Its simplicity is also its limitation. It rewards volume more readily than it recognizes clinical work, and it can leave pharmacies exposed when acquisition costs change, generic reimbursement compresses, or payment terms are unclear.<\/p>\n

For years, retrospective fees made margin management especially challenging. In Medicare Part D, the move to require pharmacy price concessions to be reflected at the point of sale has improved visibility compared with the prior system of post-adjudication direct and indirect remuneration fees. Visibility, however, does not automatically create sustainable economics. Pharmacies still need reimbursement that reflects the real cost of dispensing, patient support, compliance, labor, inventory carrying, and technology.<\/p>\n

The pressure is particularly acute for independent and community pharmacies. They operate as highly accessible healthcare sites, frequently handling medication questions, insurance problems, refill coordination, and adherence barriers without a separate billing pathway. A payment model that ignores this work may appear efficient on a claims report while shifting costs into an already stressed pharmacy operation.<\/p>\n

Future pharmacy reimbursement models will pay for more than a prescription<\/h2>\n

The most significant change is the gradual separation of product payment from professional service payment. A pharmacy may still be paid for acquiring and dispensing a medication, but it is increasingly likely to be paid separately for defined interventions that improve patient outcomes or reduce avoidable spending.<\/p>\n

Professional service fees<\/h3>\n

Medication therapy management, comprehensive medication reviews, immunizations, point-of-care testing, chronic disease education, transitions-of-care support, and prescribing authority where permitted all create opportunities for service-based payment. The opportunity is real, but it depends on clear eligibility rules, documentation standards, workflows, and payer recognition.<\/p>\n

A service is not financially sustainable simply because it is clinically valuable. Pharmacy leaders need to calculate the time required from pharmacists and technicians, training needs, supplies, scheduling capacity, documentation burden, claim denial risk, and expected payment<\/a>. In many cases, a focused service delivered to a well-defined patient population is more viable than trying to offer every possible service to every patient.<\/p>\n

Value-based arrangements<\/h3>\n

Value-based reimbursement connects some portion of payment to measured performance. Measures may include medication adherence, vaccination rates, successful therapy starts, reduced gaps in care, improved disease-control indicators, or lower avoidable utilization.<\/p>\n

This approach fits pharmacy’s expanding clinical role, but it comes with an essential caveat: pharmacies cannot be held solely responsible for outcomes they do not fully control. A patient may face transportation barriers, high out-of-pocket costs, prescriber changes, limited health literacy, or unstable insurance coverage. Fair contracts should use measures that a pharmacy can influence, provide timely access to data, and account for patient complexity.<\/p>\n

For a community pharmacy, the most practical first step may be a hybrid model. A base payment covers the essential cost of dispensing and access, while additional payments reward documented services and agreed performance measures. This reduces the risk of making the entire business dependent on metrics that may be incomplete or outside the pharmacy’s control.<\/p>\n

Cost-plus and transparent contracting<\/h3>\n

Another model gaining attention reimburses pharmacies based on a defined acquisition-cost methodology plus a transparent professional dispensing fee. Cost-plus arrangements can make economics easier to understand and reduce uncertainty around spread pricing, although they are not automatically favorable in every contract.<\/p>\n

The quality of the arrangement depends on the benchmark used, how frequently it is updated, how specialty and limited-distribution products are handled, and whether the dispensing fee reflects the pharmacy’s actual operating cost. Transparency is valuable, but pharmacy owners should still review the full contract rather than assume that a clear formula guarantees an adequate margin.<\/p>\n

Network and access payments<\/h3>\n

Payers and health systems increasingly recognize that pharmacy access is an operational asset. Pharmacies can support same-day therapy initiation, discharge medication coordination, rural access, vaccination campaigns, and care-navigation programs. In some settings, this may lead to network participation fees, care-coordination payments, or payments tied to serving high-need populations.<\/p>\n

These models can strengthen the pharmacy’s role in local care delivery. They can also create administrative complexity if each payer uses a different portal, measure set, and reporting cycle. Scale matters. A multi-store organization may centralize reporting, while an independent pharmacy may need to be selective about which arrangements justify the effort.<\/p>\n

Data will be the operating currency<\/h2>\n

No reimbursement model can reward work that is invisible. The pharmacy that wants to participate in service or value-based contracts needs reliable ways to identify eligible patients, document interventions, track follow-up, and demonstrate results.<\/p>\n

That does not mean every pharmacy must build a large analytics department. It does mean pharmacy management systems, workflow tools<\/a>, and patient communication platforms should be assessed as business infrastructure, not only as technology expenses. Can the team identify patients with adherence gaps? Can it record outreach and intervention outcomes consistently? Can managers see which services generate revenue, consume labor, and improve patient retention?<\/p>\n

Data quality also affects negotiating power. A pharmacy that can demonstrate strong vaccination performance, successful medication synchronization enrollment, or reduced therapy abandonment has a more credible position in discussions with payers, employers, and provider organizations. Anecdotal evidence of excellent care is meaningful, but measured evidence is more likely to be reimbursed.<\/p>\n

What pharmacy leaders should do now<\/h2>\n

Preparing for new reimbursement models begins with a disciplined view of the current business. Owners should know their true cost to dispense<\/a> by prescription category, payer, and workflow intensity. They should also know which patient services are already being delivered without payment and which could be standardized, documented, and billed or included in a contract proposal.<\/p>\n

Contract review deserves management attention, not just periodic administrative handling. Examine reimbursement benchmarks, appeal procedures, audit provisions, claim reversals, payment timing, data-sharing terms, and quality measures. If performance incentives are offered, ask whether the baseline is realistic, whether the data are independently verifiable, and whether the pharmacy can obtain timely reports before a performance period ends.<\/p>\n

Workforce design is equally important. Pharmacists should not be expected to add clinical services on top of uninterrupted dispensing volume without redesigning technician roles, appointment capacity, and communication processes. A practical service model protects time for the intervention and creates a consistent handoff from identification to scheduling, documentation, follow-up, and payment.<\/p>\n

Finally, pharmacy leaders should consider where they can create differentiated value in their own market. A pharmacy near a large older-adult population may prioritize adherence and medication review programs. A pharmacy serving employers may focus on immunization and preventive care. One with close local prescriber relationships may be well positioned for transitions-of-care support. The right reimbursement strategy follows the patient population and the pharmacy’s operational strengths.<\/p>\n

The strongest pharmacies will not wait for a single national model to settle the question of payment. They will make their value visible, price their services with discipline, and choose partnerships that recognize pharmacy as a care provider as well as a dispensing channel.<\/p>\n","protected":false},"excerpt":{"rendered":"

Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.<\/p>\n","protected":false},"author":41,"featured_media":75444,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","cybocfi_hide_featured_image":"","_custom_featured_image_link":"","footnotes":""},"categories":[379],"tags":[],"class_list":["post-75443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-profession-development"],"acf":[],"yoast_head":"\nFuture Pharmacy Reimbursement Models Explained - PHARMACY management TUTORIAL<\/title>\n<meta name=\"description\" content=\"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Future Pharmacy Reimbursement Models Explained\" \/>\n<meta property=\"og:description\" content=\"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/\" \/>\n<meta property=\"og:site_name\" content=\"PHARMACY management TUTORIAL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pharmamanagment\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T02:12:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2023\/06\/PM-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"soro soro ai\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@PharmMedHealth\" \/>\n<meta name=\"twitter:site\" content=\"@PharmMedHealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"soro soro ai\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/\"},\"author\":{\"name\":\"soro soro ai\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#\\\/schema\\\/person\\\/3675e8473e50f19078d6b16f7de01434\"},\"headline\":\"Future Pharmacy Reimbursement Models Explained\",\"datePublished\":\"2026-11-09T02:12:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/\"},\"wordCount\":1288,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/future-pharmacy-reimbursement-models-explained-featured.webp\",\"articleSection\":[\"Profession Development\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/\",\"url\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/\",\"name\":\"Future Pharmacy Reimbursement Models Explained - PHARMACY management TUTORIAL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/future-pharmacy-reimbursement-models-explained-featured.webp\",\"datePublished\":\"2026-11-09T02:12:37+00:00\",\"description\":\"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/future-pharmacy-reimbursement-models-explained-featured.webp\",\"contentUrl\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/future-pharmacy-reimbursement-models-explained-featured.webp\",\"width\":1536,\"height\":1024,\"caption\":\"Future Pharmacy Reimbursement Models Explained\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/future-pharmacy-reimbursement-models-explained\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Future Pharmacy Reimbursement Models Explained\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/\",\"name\":\"PHARMACY Management TUTORIAL\",\"description\":\"\u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u03b5\u03c0\u03b9\u03ba\u03b1\u03b9\u03c1\u03cc\u03c4\u03b7\u03c4\u03b1, \u03b7 \u03b4\u03b9\u03bf\u03af\u03ba\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03b7 \u03b4\u03b9\u03b1\u03c7\u03b5\u03af\u03c1\u03b9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03af\u03bf\u03c5, \u03c4\u03bf \u03bc\u03ac\u03c1\u03ba\u03b5\u03c4\u03b9\u03bd\u03b3\u03ba, \u03b7 \u03b5\u03c0\u03b9\u03ba\u03bf\u03b9\u03bd\u03c9\u03bd\u03af\u03b1 \u03ba\u03b1\u03b9 \u03b7 \u03b5\u03ba\u03c0\u03b1\u03af\u03b4\u03b5\u03c5\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#organization\"},\"alternateName\":\"PharmaManage\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#organization\",\"name\":\"PHARMACY Management TUTORIAL\",\"alternateName\":\"PharmaManage\",\"url\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PM-logo_sq.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pharmamanage.gr\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PM-logo_sq.jpg\",\"width\":696,\"height\":696,\"caption\":\"PHARMACY Management TUTORIAL\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pharmamanagment\",\"https:\\\/\\\/x.com\\\/PharmMedHealth\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/5366530\",\"https:\\\/\\\/www.instagram.com\\\/charami_sa\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pharmamanage.gr\\\/en\\\/#\\\/schema\\\/person\\\/3675e8473e50f19078d6b16f7de01434\",\"name\":\"soro soro ai\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g\",\"caption\":\"soro soro ai\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Future Pharmacy Reimbursement Models Explained - PHARMACY management TUTORIAL","description":"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/","og_locale":"en_US","og_type":"article","og_title":"Future Pharmacy Reimbursement Models Explained","og_description":"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.","og_url":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/","og_site_name":"PHARMACY management TUTORIAL","article_publisher":"https:\/\/www.facebook.com\/pharmamanagment","article_published_time":"2026-11-09T02:12:37+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2023\/06\/PM-logo.jpg","type":"image\/jpeg"}],"author":"soro soro ai","twitter_card":"summary_large_image","twitter_creator":"@PharmMedHealth","twitter_site":"@PharmMedHealth","twitter_misc":{"Written by":"soro soro ai","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#article","isPartOf":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/"},"author":{"name":"soro soro ai","@id":"https:\/\/www.pharmamanage.gr\/en\/#\/schema\/person\/3675e8473e50f19078d6b16f7de01434"},"headline":"Future Pharmacy Reimbursement Models Explained","datePublished":"2026-11-09T02:12:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/"},"wordCount":1288,"publisher":{"@id":"https:\/\/www.pharmamanage.gr\/en\/#organization"},"image":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2026\/11\/future-pharmacy-reimbursement-models-explained-featured.webp","articleSection":["Profession Development"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/","url":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/","name":"Future Pharmacy Reimbursement Models Explained - PHARMACY management TUTORIAL","isPartOf":{"@id":"https:\/\/www.pharmamanage.gr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#primaryimage"},"image":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2026\/11\/future-pharmacy-reimbursement-models-explained-featured.webp","datePublished":"2026-11-09T02:12:37+00:00","description":"Future pharmacy reimbursement models are shifting from dispensing fees to outcomes, services, and data. What pharmacy leaders should prepare right now.","breadcrumb":{"@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#primaryimage","url":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2026\/11\/future-pharmacy-reimbursement-models-explained-featured.webp","contentUrl":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2026\/11\/future-pharmacy-reimbursement-models-explained-featured.webp","width":1536,"height":1024,"caption":"Future Pharmacy Reimbursement Models Explained"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pharmamanage.gr\/en\/future-pharmacy-reimbursement-models-explained\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pharmamanage.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Future Pharmacy Reimbursement Models Explained"}]},{"@type":"WebSite","@id":"https:\/\/www.pharmamanage.gr\/en\/#website","url":"https:\/\/www.pharmamanage.gr\/en\/","name":"PHARMACY Management TUTORIAL","description":"\u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u03b5\u03c0\u03b9\u03ba\u03b1\u03b9\u03c1\u03cc\u03c4\u03b7\u03c4\u03b1, \u03b7 \u03b4\u03b9\u03bf\u03af\u03ba\u03b7\u03c3\u03b7 \u03ba\u03b1\u03b9 \u03b7 \u03b4\u03b9\u03b1\u03c7\u03b5\u03af\u03c1\u03b9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03af\u03bf\u03c5, \u03c4\u03bf \u03bc\u03ac\u03c1\u03ba\u03b5\u03c4\u03b9\u03bd\u03b3\u03ba, \u03b7 \u03b5\u03c0\u03b9\u03ba\u03bf\u03b9\u03bd\u03c9\u03bd\u03af\u03b1 \u03ba\u03b1\u03b9 \u03b7 \u03b5\u03ba\u03c0\u03b1\u03af\u03b4\u03b5\u03c5\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd.","publisher":{"@id":"https:\/\/www.pharmamanage.gr\/en\/#organization"},"alternateName":"PharmaManage","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pharmamanage.gr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pharmamanage.gr\/en\/#organization","name":"PHARMACY Management TUTORIAL","alternateName":"PharmaManage","url":"https:\/\/www.pharmamanage.gr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmamanage.gr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2023\/06\/PM-logo_sq.jpg","contentUrl":"https:\/\/www.pharmamanage.gr\/wp-content\/uploads\/2023\/06\/PM-logo_sq.jpg","width":696,"height":696,"caption":"PHARMACY Management TUTORIAL"},"image":{"@id":"https:\/\/www.pharmamanage.gr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pharmamanagment","https:\/\/x.com\/PharmMedHealth","https:\/\/www.linkedin.com\/company\/5366530","https:\/\/www.instagram.com\/charami_sa\/"]},{"@type":"Person","@id":"https:\/\/www.pharmamanage.gr\/en\/#\/schema\/person\/3675e8473e50f19078d6b16f7de01434","name":"soro soro ai","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/806c8da4bc9f0b2831ce670f4686b4c5a760f451ca1f12944a806a3ac3e29f3e?s=96&d=mm&r=g","caption":"soro soro ai"}}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/posts\/75443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/comments?post=75443"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/posts\/75443\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/media\/75444"}],"wp:attachment":[{"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/media?parent=75443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/categories?post=75443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmamanage.gr\/en\/wp-json\/wp\/v2\/tags?post=75443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}